Literature DB >> 15869724

The efficacy of conventional external beam, three-dimensional conformal, intensity-modulated, particle beam radiation, and brachytherapy for localized prostate cancer.

Tony Y Eng1, Join Y Luh, Charles R Thomas.   

Abstract

Technologic advances in radiation treatment planning and delivery have generated popular interest in the different radiation therapy techniques used in treating patients with localized prostate cancer. Throughout the past decade, high-energy (> 4 MV) linear accelerators have largely replaced Cobalt machines in external beam radiation therapy (EBRT) delivery. Conventional EBRT has been used to treat prostate cancer successfully since the 1950s. By switching to computed tomography-based planning, three-dimensional conformal radiation therapy provides better relative conformality of dose than does conventional EBRT. Intensity-modulated radiation therapy (IMRT) has further refined dose conformality by spreading the low-dose region to a larger volume. However, the potential long-term risks of larger volumes of normal tissues receiving low doses of radiation in IMRT are unknown. Particle-beam radiation therapy offers unique dose distributions and characteristics with higher relative biologic effect and linear energy transfer. Transperineal prostate brachytherapy offers the shortest treatment time with equivalent efficacy without significant risk of radiation exposure. The addition of hormonal therapy to radiation therapy has been shown to improve the outcome of radiation therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15869724     DOI: 10.1007/s11934-005-0008-3

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  121 in total

1.  Definitive radiation therapy of carcinoma of the prostate. A report on 15 years of experience.

Authors:  G R Ray; J R Cassady; M A Bagshaw
Journal:  Radiology       Date:  1973-02       Impact factor: 11.105

2.  Whole abdominal irradiation by a moving-strip technique for patients with ovarian cancer.

Authors:  A J Dembo; J Van Dyk; B Japp; H A Bean; F A Beale; J F Pringle; R S Bush
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979 Nov-Dec       Impact factor: 7.038

Review 3.  The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate.

Authors:  S A Leibel; M J Zelefsky; G J Kutcher; C M Burman; R Mohan; G S Mageras; C C Ling; Z Fuks
Journal:  Semin Oncol       Date:  1994-10       Impact factor: 4.929

4.  Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy.

Authors:  G E Hanks; A L Hanlon; W H Pinover; E M Horwitz; T E Schultheiss
Journal:  Cancer J Sci Am       Date:  1999 May-Jun

5.  Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer.

Authors:  M J Zelefsky; Z Fuks; L Happersett; H J Lee; C C Ling; C M Burman; M Hunt; T Wolfe; E S Venkatraman; A Jackson; M Skwarchuk; S A Leibel
Journal:  Radiother Oncol       Date:  2000-06       Impact factor: 6.280

6.  Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablation.

Authors:  G K Zagars; A Pollack; A C von Eschenbach
Journal:  Cancer       Date:  1997-08-15       Impact factor: 6.860

7.  Pion conformal radiation of prostate cancer: results of a randomized study.

Authors:  T Pickles; G B Goodman; C J Fryer; J Bowen; A J Coldman; G G Duncan; P Graham; M McKenzie; W J Morris; D E Rheaume; I Syndikus
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-01-01       Impact factor: 7.038

Review 8.  Localized carcinoma of the prostate (stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy.

Authors:  C A Perez; G E Hanks; S A Leibel; A L Zietman; Z Fuks; W R Lee
Journal:  Cancer       Date:  1993-12-01       Impact factor: 6.860

9.  Radiation exposure to family and household members after prostate brachytherapy.

Authors:  Jeff Michalski; Sasa Mutic; John Eichling; S Nisar Ahmed
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-07-01       Impact factor: 7.038

10.  Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome.

Authors:  G K Zagars; A Pollack
Journal:  Urology       Date:  1995-03       Impact factor: 2.649

View more
  2 in total

1.  Residual translational and rotational errors after kV X-ray image-guided correction of prostate location using implanted fiducials.

Authors:  Reinhold Graf; Dirk Boehmer; Volker Budach; Peter Wust
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

2.  Interstitial brachytherapy guided intensity modulated radiation therapy (IBGIMRT) in cervical cancer: a dosimetric study.

Authors:  Daya Nand Sharma; V Subramani; Goura Kisor Rath; K S Jothybasu; Amit Bahl; Parmod Kumar Julka; N Gopishankar
Journal:  J Contemp Brachytherapy       Date:  2009-07-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.